Interview with Rathnam Chaguturu, USA, about the current status of drug discovery in industry and academia

Interview with Rathnam Chaguturu, USA, about the current status of drug discovery in industry and academia
Bruce Lipshutz, University of California, talks about his amazement of what is possible and the big challenge of altering the current practice of organic chemistry
John LaMattina, former President, Pfizer Global R&D, on the changes, challenges, and misconceptions in the pharma industry
L. Starkey, California State Polytechnic University, lets students discover how interesting and even fun organic synthesis can be
Stephane Caron, Pfizer, talks about the challenges facing synthetic chemists and how to choose a synthetic strategy
Andrew Teasdale, AstraZeneca, talks about his book on genotoxic impurities and what constitutes an acceptable drug risk
Francis Waller talks about common intellectual property issues for chemists from his 30 years experience of filing patents